SCHEMBL2395042

SCHEMBL2395042

O=C(O)c1ccc(S(=O)(=O)Nc2cc3c4c(c2)CCCC4CCC3)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 4/20 0.59
KMT2A Q03164 3/20 0.59
ALDH1A1 P00352 3/20 0.59
MEN1 O00255 2/20 0.59
ING2 Q9H160 1/20 0.55
CYP1A2 P05177 1/20 0.54
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA9 Q16790 1/20 0.49
WDR5 P61964 1/20 0.48
GAA P10253 2/20 0.46
METAP2 P50579 1/20 0.44
MAPT P10636 2/20 0.44
TP53 P04637 1/20 0.44
GFER P55789 1/20 0.43
NLRP3 Q96P20 1/20 0.43
LMNA P02545 1/20 0.43
THRB P10828 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL829800 0.80 ALDH1A1 (0.41) POLBKMT2AALDH1A1MEN1CYP1A2
SCHEMBL2394947 0.79 RAB9A (0.52) POLBKMT2AALDH1A1MEN1GAA
SCHEMBL2394756 0.78 ING2 (0.53) POLBKMT2AALDH1A1MEN1ING2
SCHEMBL830021 0.76 KMO (0.42) POLBKMT2AALDH1A1MEN1CYP1A2
SCHEMBL2394945 0.75 RAB9A (0.51) POLBKMT2AALDH1A1MEN1GAA
SCHEMBL2394763 0.75 MEN1 (0.54) KMT2AALDH1A1MEN1CYP1A2GAA
SCHEMBL828937 0.74 ALDH1A1 (0.48) POLBKMT2AALDH1A1MEN1CYP1A2
SCHEMBL2393053 0.72 MEN1 (0.52) KMT2AALDH1A1MEN1CYP1A2GAA
SCHEMBL13790034 0.72 ALDH1A1 (0.46) POLBKMT2AALDH1A1MEN1CYP1A2
SCHEMBL19818223 0.71 ING2 (1.00) POLBKMT2AMEN1ING2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2189443-B1 TRICYCLIC AMIDE COMPOUND RES FOUND ITSUU LAB (JP) 2013-10-23 EP disclosed
US-8232300-B2 Tricyclic amide compound RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2012-07-31 US disclosed
US-8232300-B2 Tricyclic amide compound RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2012-07-31 US disclosed
US-20110213157-A1 TRICYCLIC AMIDE COMPOUND RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2011-09-01 US disclosed
US-20110213157-A1 TRICYCLIC AMIDE COMPOUND RESEARCH FOUNDATION ITSUU LABORATORY (JP) 2011-09-01 US disclosed
EP-2189443-A1 TRICYCLIC AMIDE COMPOUND Research Foundation Itsuu Laboratory (JP) 2010-05-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110213157-A1 TRICYCLIC AMIDE COMPOUND RXRA, RXRB, RXRG POLB 2195/4885KMT2A 1560/4885ALDH1A1 761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.